|
Roche Holding Ltd.
|
Grenzacherstrasse 124
4070 Basel
Switzerland |
| Tel: |
41 61 688 11 11 |
| URL: |
http://www.roche.com/ |
|
| Formerly known as: |
| Roche Holding AG |
 |
| Primary Symbols & Exchanges: |
| RO - SWX Swiss Exchange |
| RHHBY - Pink Sheets |
| ROG - SWX Swiss Exchange |
|
|
| Primary Industry: |
| Pharmaceutical |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activities are to discover, develop, manufacture and market novel health care solutions. The Group operates through two segments namely Pharmaceuticals and Diagnostics. The Pharmaceuticals division includes prescription and manufacturing of pharmaceutical products. The Pharmaceutical segment has three sub-divisions namely Roche Prescription, Genentech Prescription and Chugai Prescription. Diagnostic segment provides products and services in all fields of medical testing. It also provides reagents and test kits for molecular and cell biology, analytical systems and reagents for clinical chemistry, immunochemistry, hematology and coagulation. Diagnostics division consists of five business areas: Diabetes Care, Near Patient Testing, Centralized Diagnostics, Molecular Diagnostics and Applied Science. It operates in Switzerland, European Union, United States, North America, Latin America, Japan, Asia, Africa, Australia and Oceania. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Roche Holding Ltd.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
